How platform trials are improving childhood cancer treatment | University of Birmingham @unibirmingham
How platform trials are improving childhood cancer treatment | University of Birmingham  @unibirmingham
Uploaded May 2026 | Updated November 2026, 4 days ago
Whilst survival rates for childhood cancers have improved dramatically, treatment options for children and young people are limited due to the small populations of patients. Therefore, developing treatment methods can be challenging due to constraints generating robust evidence.

Professor Amos Burke, Professor of Paediatric Oncology at the University of Birmingham leads an international platform trial for children and young people with relapsed or refractory B-cell Hodgkin lymphoma. The trial, Glo BNHL, brings together global expertise through a single, flexible trial infrastructure, enabling multiple treatments to be tested within the same rare disease population.

Read the article to find out more about our paediatric cancer trials research: birmingham.ac.uk/news/2026/a-blueprint-for-faster-fairer-drug-development-in-rare-childhood-cancers
How platform trials are improving childhood cancer treatment | University of Birmingham#Placement opportunities for #PGCE students at the #universityofbirminghamDeveloping treatments for childhood cancers | University of BirminghamCollege of Medicine and Health, Tuesday 14th July, 3.00pm | Summer Degree CeremoniesHappy Tolkien Day! Looking at the legacy of #Tolkien and his booksWelcome Week | International Students | University of BirminghamDiscovering this University’s link with JRR TolkienStronger Together: Empowering community action to prevent youth suicide | University of BirminghamResearch for Greener Surgery Conference 2025 | University of BirminghamDesigning clinical trials around patients lives | University of BirminghamPOV: You arrive on campus and see our icons for the first time!Can you guess the country before we do? | University of Birmingham
University of Birmingham |

How platform trials are improving childhood cancer treatment | University of Birmingham

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER